Bioscience company working on the standardization of proteomics for clinical use
Evosep has raised €37M across 1 funding round from 1 investor, most recently a round in Jan 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-09 | Other | €37M |
| Novo Holdings |
| View deal → |
